Feasibility study of Capecitabine as adjuvant chemotherapy for stage III colon cancer including RS [rectosigmoid] cancer.

Trial Profile

Feasibility study of Capecitabine as adjuvant chemotherapy for stage III colon cancer including RS [rectosigmoid] cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 May 2017

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 25 May 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 22 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top